Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
51.2% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
1
users have commented on this narrative
32
users have followed this narrative
6 days ago
author updated this narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
6.7% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
24.6% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
2
users have commented on this narrative
29
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
53.6% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
1
users have commented on this narrative
5
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Harvard Bioscience
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Demographic Shifts And NIH Funding Will Unlock Biomedical Potential
Key Takeaways Strong alignment with biomedical research trends and expanding proprietary technology platforms positions the company well for sustained growth and margin improvement. Enhanced operational efficiency and capital restructuring increase financial flexibility, supporting continued investment in innovation and long-term profitability.
View narrative
US$3.00
FV
81.9% undervalued
intrinsic discount
1.42%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
12 days ago
author updated this narrative
Aecon Group
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Electrification And Nuclear Projects Will Transform US And Canadian Infrastructure
Key Takeaways Strategic focus on energy transition infrastructure, collaborative contracts, and recurring revenue streams is strengthening margin stability and reducing earnings volatility. Enhanced balance sheet and market positioning support sustained growth, expanded project opportunities, and optionality for margin and earnings expansion.
View narrative
CA$23.27
FV
12.2% undervalued
intrinsic discount
5.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
25
users have followed this narrative
12 days ago
author updated this narrative
XP
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Brazil's Rising Middle Class Will Drive Digital Finance Expansion
Key Takeaways Rapid expansion of advisor productivity and new product cross-selling is accelerating client acquisition and shifting revenue mix, fueling long-term growth and higher margins. Structural advantages in financial inclusion and digital innovation position XP to capture substantial market share and sustain outsized asset and earnings growth in Brazil.
View narrative
US$25.41
FV
34.0% undervalued
intrinsic discount
17.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
12 days ago
author updated this narrative
Ekso Bionics Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Advanced Exoskeleton Devices Will Broaden Rehabilitation Market Access
Key Takeaways Accelerated adoption and revenue growth are expected from improved reimbursement, regulatory changes, and expanded distribution partnerships. Ongoing AI-driven innovation and recovery of delayed sales position Ekso Bionics for enhanced margins and future earnings stability.
View narrative
US$6.75
FV
44.6% undervalued
intrinsic discount
22.40%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
12 days ago
author updated this narrative
Organogenesis Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
CMS Reform And Capacity Expansion Will Unlock Long Term Value
Key Takeaways Regulatory changes and clinical evidence efforts are set to boost adoption, payer coverage, and margins for premium wound care products. Facility expansion and new product launches position the company for diversified, long-term growth and improved efficiency.
View narrative
US$8.00
FV
39.8% undervalued
intrinsic discount
20.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
12 days ago
author updated this narrative
Similarweb
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
AI And Digital Analytics Will Unlock New Opportunities
Key Takeaways Strong enterprise adoption of advanced AI-driven analytics and multiyear contracts is boosting recurring revenue, earnings visibility, and long-term profitability. Expansion into new analytics markets and continuous product innovation are increasing market opportunity and customer retention through differentiated, high-value offerings.
View narrative
US$13.25
FV
29.4% undervalued
intrinsic discount
17.03%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
28
users have followed this narrative
12 days ago
author updated this narrative
Hiab Oyj
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Eco Transition And Automation Will Shape Future Markets
Key Takeaways Strong growth in eco-friendly products and services is driving higher margins and supporting stable, long-term profitability. Strategic investments in automation, digitalization, and efficiency initiatives strengthen market position and enhance revenue and earnings growth.
View narrative
€59.00
FV
2.3% undervalued
intrinsic discount
4.07%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
12 days ago
author updated this narrative
JGC Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Global Energy Transition And Capital Projects Will Drive Stability
Key Takeaways Recovery in fine chemicals and fine ceramics offsets engineering volatility, supporting improved margins and earnings stability. Strong project pipeline and enhanced governance drive recurring, higher-margin revenue and better cost control across energy transition and maintenance sectors.
View narrative
JP¥1.32k
FV
6.1% overvalued
intrinsic discount
-3.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
12 days ago
author updated this narrative
Shivalik Bimetal Controls
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
India Smart Meter Production And EV Trends Will Expand Markets
Key Takeaways Rising domestic manufacturing, government policy, and electrification are driving strong demand and market share growth, with advanced assemblies expanding revenue streams. Export gains from electric vehicle trends and localization, along with R&D and efficiency improvements, are diversifying risk and sustaining margins and innovation.
View narrative
₹734.00
FV
29.1% undervalued
intrinsic discount
19.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
12 days ago
author updated this narrative
Value any company in seconds
Popular companies